Inventor · disambiguated record
Laura Gleave
Also filed as: GLEAVE LAURA · GLEAVE LAURA JANE
7 granted patents·4 pending applications·14 citations·filing 2013–2024
78Inventor score
Top patents by PatentIndex Score
11 records- 0178US11198681B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Dec 14, 2021·4 cites·15 claims
- 0275US9309243B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2013·Granted Apr 12, 2016·4 cites·11 claims
- 0374US9475820B2Substituted imidazo[1,2-a]pyrazines as TNF activity modulatorsUCB BIOPHARMA SPRL·Filed 2013·Granted Oct 25, 2016·3 cites·14 claims
- 0471US12502380B2MrgprX2 antagonists for the treatment of inflammatory disordersDERMIRA INC·Filed 2024·Granted Dec 23, 2025·0 cites·18 claims
- 0570US9963448B2Bicyclic inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·2 cites·20 claims
- 0666US9765093B2Aza-benzimidazole inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted Sep 19, 2017·1 cites·17 claims
- 0762US11897866B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2021·Granted Feb 13, 2024·0 cites·15 claims
- 0855US2025289793A1Macrocyclic inhibitors of atp citrate lyaseESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0953US2023029266A1MrgprX2 Antagonists for the Treatment of Inflammatory DisordersDERMIRA INC·Filed 2020·Application pending·0 cites
- 1043US2023027929A1MrgprX2 Antagonists and Uses ThereofDERMIRA INC·Filed 2020·Application pending·0 cites
- 1142US2023002336A1MrgprX2 Antagonists and Uses ThereofDERMIRA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laura Gleave files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →